2023
DOI: 10.1016/j.jaad.2023.06.044
|View full text |Cite
|
Sign up to set email alerts
|

Tumor size is the most significant risk factor for local recurrence in dermatofibrosarcoma protuberans: A large-scale retrospective cohort analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…The management of DFSP adopts a multidisciplinary approach, tailored to the tumor's unique behavior. Surgical excision serves as the primary modality, with the extent of resection and adjuvant therapies adjusted according to tumor size, location, and recurrence risk [12]. In advanced or unresectable cases, Imatinib, a tyrosine kinase inhibitor targeting PDGF receptor (PDGFR) pathways, has emerged as a promising therapeutic avenue [13,14].…”
Section: Introductionmentioning
confidence: 99%
“…The management of DFSP adopts a multidisciplinary approach, tailored to the tumor's unique behavior. Surgical excision serves as the primary modality, with the extent of resection and adjuvant therapies adjusted according to tumor size, location, and recurrence risk [12]. In advanced or unresectable cases, Imatinib, a tyrosine kinase inhibitor targeting PDGF receptor (PDGFR) pathways, has emerged as a promising therapeutic avenue [13,14].…”
Section: Introductionmentioning
confidence: 99%